SHARPIN and cutaneous mastocytosis: identified MBP, SAMSN1, PSMF1, SLC39A8, EIF3B, SMPDL3A, FABP5, SPSB3, and SHARPIN genes, which were associated with CM, and suggested that these genes may be good potential targets or immune modulators for novel therapeutic interventions of CM (Li et al., 2021).